Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 232 M244 M238 M239 M243 M267 M 987 M Research & development —————— — Operating income 109 M139 M156 M118 M138 M150 M 562 M Non-Operating Income, Total -3 M-4 M0-4 M-1 M191 M 186 M Interest expense, net of interest capitalized 12 M10 M10 M9 M8 M5 M 32 M Non-Operating Income, excl. Interest Expenses -3 M-2 M-12 M-14 M-9 M184 M 149 M Unusual income/expense 0-2 M2 M1 M02 M 5 M Pretax income 94 M125 M146 M105 M129 M338 M 718 M Equity in earnings —————— — Taxes 23 M28 M40 M34 M32 M84 M 190 M Non-controlling/minority interest 4 M6 M6 M4 M5 M8 M 23 M After tax other income/expense -6 M-5 M-7 M10 M-4 M-2 M -3 M Net income before discontinued operations 67 M91 M100 M67 M92 M246 M 505 M Discontinued operations —————— — Net income 67 M91 M100 M67 M92 M246 M 505 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 67 M91 M100 M67 M92 M246 M 505 M Basic earnings per share (Basic EPS) 0.340.450.50.330.461.22 2.51 Diluted earnings per share (Diluted EPS) 0.330.450.490.330.451.21 2.48 Average basic shares outstanding 200 M201 M201 M201 M201 M202 M — Diluted shares outstanding 203 M203 M203 M203 M204 M204 M — EBITDA 151 M182 M199 M156 M180 M192 M 727 M EBIT 106 M136 M153 M105 M133 M146 M 537 M Cost of revenue 364 M393 M389 M395 M377 M399 M 1.56 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 45 M46 M46 M51 M47 M46 M 190 M